This is the login page for PHARMA JAPAN WEB subscribers. PHARMA JAPAN WEB offers excerpts of some articles for free, but paid subscription is required to read full articles.

Today's Headlines RSS

BUSINESS

Takeda Aims for Consecutive Sales Growth through FY2022

Takeda Pharmaceutical President Christophe Weber said on October 30 that the company aims to achieve a continual sales increase through FY2022 with the growth of innovative drugs, generics, and OTC ... > Read full story
BUSINESS
Sumitomo Dainippon’s Sales Down 1.7% on Drug Price Cuts in Japan (Oct.31)
BUSINESS
Eisai Flounders in Japan, US Markets, Half-Year Profits Dive 60% (Oct.31)
REGULATORY
Cabinet OKs Appointment of Keio Prof as Japan NIH Head (Oct.31)
BUSINESS
Takeda Reports 2.8% Rise in First-Half Sales (Oct.31)
REGULATORY
MHLW to Issue Notification with Survey Form on Adverse Reactions to HPV Vaccines (Oct.31)
> More Latest News

Photosmore

  
Eisai Flounders in Japan, US Markets, Half-Year Profits Dive 60% (Oct.31)Smaller Crestor Royalties Send Shionogi’s April-Sept. Sales Lower (Oct.30)MTPC’s Half-Year Sales Dip, but Operating Profit Jumps on Gilenya Royalties (Oct.30)
  
Off-Label Use of Avigan Allowed for Ebola Treatment: Health Ministry Panel (Oct.28)Health Ministry Panel Agrees to Regulate Clinical Research by Law (Oct.24)Trade Groups Seek Insurance Coverage for Conditionally Approved Regenerative Medicine Products (Oct.24)

News Categories

REGULATORY
   Cabinet OKs Appointment of Keio Prof as Japan NIH Head(Oct.31)
   MHLW to Issue Notification with Survey Form on Adverse Reactions to HPV Vaccines(Oct.31)
   Lantus Biosimilars Likely to Be OKed by Year-End: First Committee(Oct.30)
BUSINESS
   Takeda Aims for Consecutive Sales Growth through FY2022(Oct.31)
   Sumitomo Dainippon’s Sales Down 1.7% on Drug Price Cuts in Japan(Oct.31)
   Eisai Flounders in Japan, US Markets, Half-Year Profits Dive 60%(Oct.31)
ORGANIZATION
   EFPIA Japan Official Calls for More-Effective Use of Surplus Raw Plasma(Oct.30)
   April-June Generic Share at 49.8% under New Formula: JGA(Oct.29)
   JPMA to Launch Compound Library Joint Purchasing Initiative; Full-Scale Purchasing to Begin in FY2015(Oct.29)
ACADEMIA
   ICH-GCP Compliance Obligatory for Clinical Studies Conducted by Chiba University(Oct.28)
   Chiba University Issues Warning to Prof. Involved in VART Study(Oct.28)
   JSH to Draft Guidelines on Clinical Research with Company Funding(Oct.21)

Commentary

Ex-Health Minister Tamura’s Clout Likely to Grow in Nagatacho

Lexicon

PMDA-WEST:
医薬品医療機器総合機構関西支部

The Column

3 Reasons Why KOL Management Is No Longer Enough

Archives

MTPC Files Remicade for Behcet’s Disease with Special Lesions(Oct.31)
Topical Combination Psoriasis Treatment Dovobet Debuts; Expected to Improve Patient QOL, Medication Adherence(Oct.31)
Smaller Crestor Royalties Send Shionogi’s April-Sept. Sales Lower(Oct.30)
Lantus Biosimilars Likely to Be OKed by Year-End: First Committee(Oct.30)
MTPC’s Half-Year Sales Dip, but Operating Profit Jumps on Gilenya Royalties(Oct.30)

Most Read

1.
Health Ministry...
2.
MHLW Orders Rev...
3.
MHLW Orders Rev...
4.
Janssen Ordered...
5.
Takeda Gains Wo...

News Calendar